UCSF is working to create an online platform that health workers around the world can use to predict where malaria is likely to be transmitted using data on Google Earth Engine.
September 10, 2014
April 29, 2014
Over the past 18 months, physicians in California have observed on rare occasions what may be a new disease, one in which patients, usually children, quickly and permanently lose muscle function in an arm or leg.
December 12, 2013
UC San Francisco’s Global Health Group has received a $15 million grant from the Bill & Melinda Gates Foundation for a pioneering effort to help nearly three dozen countries eliminate malaria within their borders.
July 24, 2013
UCSF researchers are recommending six comprehensive measures to prevent the spread of hepatitis C for the estimated 31,000 young people who may be newly infected each year in the U.S. due to injection-drug use.
August 29, 2012
Despite nearly three decades of conflict, Sri Lanka has succeeded in reducing malaria cases by 99.9 percent since 1999 and is on track to eliminate the disease entirely by 2014.
May 30, 2012
After being infected with simian immunodeficiency virus (SIV) in a laboratory study, rhesus macaques that had more of a certain type of immune cell in their gut than others had much lower levels of the virus in their blood, and for six months after infection were better able to control the virus.
May 21, 2012
A team of researchers from UCSF and UC San Diego has identified an approved arthritis drug that is effective against amoebas in lab and animal studies, suggesting it could offer a low-dose, low cost treatment for the amoebic infections that cause human dysentery throughout the world.
May 17, 2012
Viral hepatitis chronically infects between 3.5 and 5.2 million people in the U.S. – more than 30,000 in San Francisco, alone – but only about one in three people who are infected know it, according to a report by the U.S. Department of Health and Human Services.
April 24, 2012
To celebrate World Malaria Day 2012, on Wednesday, April 25, the UCSF Global Health Group and local non-profit Zagaya are hosting the Bay Area World Malaria Day Symposium.
February 29, 2012
A drug once taken by people with HIV/AIDS, but long ago shelved after newer, modern antiretroviral therapies became available, has now shed light on how the human body uses its natural immunity to fight the virus — work that could help uncover new targets for drugs.